Literature DB >> 9198225

Mechanisms initiating platelet thrombus formation.

Z M Ruggeri1.   

Abstract

The functions of platelets depend on their ability to interest with surface exposed at sites of tissue damage and then with one another after activation, thus aggregating into thrombi. This complex process, normally beneficial to arrest bleeding during hemostasis, may become a cause of catastrophic disease when it leads to thrombotic occlusion of atherosclerotic vessels curtailing arterial blood flow to vital organs. Fluid dynamic conditions modulate all aspects of platelet response to vascular injury. At higher levels of shear stress, encountered both in normal vessels during normal hemostasis or in pathological conditions of the vasculature during thrombosis, von Willebrand factor becomes the essential adhesive protein for both adhesion and aggregation. Two platelet membrane receptors, the glycoprotein complexes Ib-IX-V and IIb-IIIa (integrin alpha IIb beta 3), mediate the von Willebrand factor function in a coordinate and synergistic manner, each contributing unique biomechanical properties to support thrombus formation. The developing understanding of the structure and mechanism of action of the key adhesive domains of von Willebrand factor, as well as of their cognate cellular and extracellular binding sites, will provide solid pathophysiological foundation for the evaluation of novel anti-thrombotic strategies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9198225

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  56 in total

1.  Coronary angioplasty enhances platelet reactivity through von Willebrand factor release.

Authors:  D A Gorog; H Douglas; N Ahmed; D C Lefroy; G J Davies
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

2.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  The mechanism of VWF-mediated platelet GPIbalpha binding.

Authors:  Matthew Auton; Cheng Zhu; Miguel A Cruz
Journal:  Biophys J       Date:  2010-08-09       Impact factor: 4.033

4.  Enzymes that hydrolyze adenine nucleotides in platelets and polymorphisms in the alpha2 gene of integrin alpha2beta1 in patients with von Willebrand disease.

Authors:  Karen Freitas Santos; Vanessa Battisti; Maísa de Carvalho Corrêa; Thaís Rapachi Mann; Renata da Silva Pereira; Maria do Carmo Araújo; Alice Odete Brülê; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Mol Cell Biochem       Date:  2010-03-25       Impact factor: 3.396

5.  Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor.

Authors:  Maneesh Arya; Anatoly B Kolomeisky; Gabriel M Romo; Miguel A Cruz; José A López; Bahman Anvari
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

Review 6.  Platelet GP Ib/IX/V complex: physiological role.

Authors:  J Rivera; M L Lozano; J Corral; R González-Conejero; C Martínez; V Vicente
Journal:  J Physiol Biochem       Date:  2000-12       Impact factor: 4.158

7.  The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.

Authors:  Conglei Li; Siavash Piran; Pingguo Chen; Sean Lang; Alessandro Zarpellon; Joseph W Jin; Guangheng Zhu; Adili Reheman; Dianne E van der Wal; Elisa K Simpson; Ran Ni; Peter L Gross; Jerry Ware; Zaverio M Ruggeri; John Freedman; Heyu Ni
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

8.  Discrimination between red blood cell and platelet components of blood clots by MR microscopy.

Authors:  Jernej Vidmar; Igor Sersa; Eduard Kralj; Gregor Tratar; Ales Blinc
Journal:  Eur Biophys J       Date:  2008-05-01       Impact factor: 1.733

9.  Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates.

Authors:  H Matsuno; O Kozawa; S Nagashima; M Kanamaru; T Uematsu
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

10.  Hematopoietic lineage cell specific protein 1 (HS1) is a functionally important signaling molecule in platelet activation.

Authors:  Bryan N Kahner; Robert T Dorsam; Sripal R Mada; Soochong Kim; Timothy J Stalker; Lawrence F Brass; James L Daniel; Daisuke Kitamura; Satya P Kunapuli
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.